Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N L Liberato

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
British Journal of Cancer|September 22, 1998
Cost-effectiveness of recombinant human erythropoietin in the prevention of chemotherapy-induced anaemiaG Barosi, M Marchetti, N L Liberato
Haematologica|May 1, 1996
Beyond BayesM Marchetti, N L Liberato, G Barosi
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1997
Cost-effectiveness of interferon alfa in chronic myelogenous leukemiaN L Liberato, S Quaglini, G Barosi
Haematologica|July 1, 1990
Erythropoietin: biological aspects and clinical usefulnessN L Liberato, A Costa, G Barosi
Haematologica|January 4, 1998
Warfarin resistance induced by teicoplaninF G Agosta, N L Liberato, F Chiofalo
Haematologica|July 1, 1990
[Cytoreductive effect of recombinant alfa-interferon in patients with myelofibrosis with myeloid metaplasia]G Barosi, N L Liberato, A Costa, et al.
Haematologica|August 24, 1999
Long-term cost-effectiveness of low molecular weight heparin versus unfractionated heparin for the prophylaxis of venous thromboembolism in elective hip replacementM Marchetti, N L Liberato, N Ruperto, et al.
Haematologica|January 1, 1996
Autoimmune hemolytic anemia in multicentric Castleman's diseaseN L Liberato, P Bollati, F Chiofalo, et al.
Acta Haematologica|January 1, 1989
Myelofibrosis with myeloid metaplasia following essential thrombocythaemiaN L Liberato, G Barosi, A Costa, et al.
Lancet (London, England)|October 17, 1992
Bromocriptine-induced acute hepatitisN L Liberato, M Poli, P Bollati, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
British Journal of Cancer|September 22, 1998
Cost-effectiveness of recombinant human erythropoietin in the prevention of chemotherapy-induced anaemiaG Barosi, M Marchetti, N L Liberato
Haematologica|May 1, 1996
Beyond BayesM Marchetti, N L Liberato, G Barosi
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1997
Cost-effectiveness of interferon alfa in chronic myelogenous leukemiaN L Liberato, S Quaglini, G Barosi
Haematologica|July 1, 1990
Erythropoietin: biological aspects and clinical usefulnessN L Liberato, A Costa, G Barosi
Haematologica|January 4, 1998
Warfarin resistance induced by teicoplaninF G Agosta, N L Liberato, F Chiofalo
Haematologica|July 1, 1990
[Cytoreductive effect of recombinant alfa-interferon in patients with myelofibrosis with myeloid metaplasia]G Barosi, N L Liberato, A Costa, et al.
Haematologica|August 24, 1999
Long-term cost-effectiveness of low molecular weight heparin versus unfractionated heparin for the prophylaxis of venous thromboembolism in elective hip replacementM Marchetti, N L Liberato, N Ruperto, et al.
Haematologica|January 1, 1996
Autoimmune hemolytic anemia in multicentric Castleman's diseaseN L Liberato, P Bollati, F Chiofalo, et al.
Acta Haematologica|January 1, 1989
Myelofibrosis with myeloid metaplasia following essential thrombocythaemiaN L Liberato, G Barosi, A Costa, et al.
Lancet (London, England)|October 17, 1992
Bromocriptine-induced acute hepatitisN L Liberato, M Poli, P Bollati, et al.
Pageof 2